| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |